BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Redfern WS, Ewart LC, Lainée P, Pinches M, Robinson S, Valentin J. Functional assessments in repeat-dose toxicity studies: the art of the possible. Toxicol Res 2013;2:209. [DOI: 10.1039/c3tx20093k] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Kremer JJ, Bills AJ, Hanke NJ, Chen H, Meier WA, Osinski MA, Foley CM. Evaluation of cardiovascular changes in dogs administered three positive controls using jacketed external telemetry-blood pressure (JET-BP). Journal of Pharmacological and Toxicological Methods 2015;75:27-37. [DOI: 10.1016/j.vascn.2015.05.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
2 Xing G, Lu J, Hu M, Wang S, Zhao L, Zheng W, Schofield J, Oldman K, Adkins D, Yu H, Platz S, Ren J, Skinner M. Effects of group housing on ECG assessment in conscious cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods 2015;75:44-51. [DOI: 10.1016/j.vascn.2015.05.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
3 Amouzadeh HR, Engwall MJ, Vargas HM. Safety Pharmacology Evaluation of Biopharmaceuticals. Handb Exp Pharmacol 2015;229:385-404. [PMID: 26091648 DOI: 10.1007/978-3-662-46943-9_15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Cavero I, Holzgrefe H. 15th Annual Meeting of the Safety Pharmacology Society: Focus on traditional sensory systems. J Pharmacol Toxicol Methods 2017;83:55-71. [PMID: 27659846 DOI: 10.1016/j.vascn.2016.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Redfern WS, Dymond A, Strang I, Storey S, Grant C, Marks L, Barnard C, Heys C, Moyser K, Greenwood K, Cobey D, Moore N, Karp NA, Prior H. The functional observational battery and modified Irwin test as global neurobehavioral assessments in the rat: Pharmacological validation data and a comparison of methods. Journal of Pharmacological and Toxicological Methods 2019;98:106591. [DOI: 10.1016/j.vascn.2019.106591] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ahuja V, Sharma S. Drug safety testing paradigm, current progress and future challenges: an overview. J Appl Toxicol 2014;34:576-94. [PMID: 24777877 DOI: 10.1002/jat.2935] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
7 Milliken P, Aylott M, Edmunds N, Engle S, Ewart L, Fleurance R, Guffroy M, Hargreaves A, Heinz-taheny K, Kirk S, Leishman D, Leong L, Mcmahon N, Valentin J, Watson D, Wallis R, Clements P. Evaluating Associations Between Nonclinical Cardiovascular Functional Endpoints and Repeat-dose Cardiovascular Toxicity in the Beagle Dog: A Cross-company Initiative. Toxicological Sciences 2020;176:224-35. [DOI: 10.1093/toxsci/kfaa051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Redfern WS. Inclusion of Safety Pharmacology Endpoints in Repeat-Dose Toxicity Studies. In: Pugsley MK, Curtis MJ, editors. Principles of Safety Pharmacology. Berlin: Springer Berlin Heidelberg; 2015. pp. 353-81. [DOI: 10.1007/978-3-662-46943-9_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
9 Hothorn LA. Statistical evaluation of toxicological bioassays – a review. Toxicol Res 2014;3:418-32. [DOI: 10.1039/c4tx00047a] [Cited by in Crossref: 27] [Cited by in F6Publishing: 1] [Article Influence: 3.4] [Reference Citation Analysis]
10 Jackson SJ, Authier S, Brohmann H, Goody SM, Jones D, Prior H, Rosch A, Traebert M, Tse K, Valentin JP, Milne A. Neurofunctional test batteries in safety pharmacology – Current and emerging considerations for the drug development process. Journal of Pharmacological and Toxicological Methods 2019;100:106602. [DOI: 10.1016/j.vascn.2019.106602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Benjamin A, Nogueira da Costa A, Delaunois A, Rosseels ML, Valentin JP. Renal Safety Pharmacology in Drug Discovery and Development. Handb Exp Pharmacol 2015;229:323-52. [PMID: 26091646 DOI: 10.1007/978-3-662-46943-9_13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Bass AS, Hombo T, Kasai C, Kinter LB, Valentin JP. A Historical View and Vision into the Future of the Field of Safety Pharmacology. Handb Exp Pharmacol 2015;229:3-45. [PMID: 26091634 DOI: 10.1007/978-3-662-46943-9_1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mow T, Andersen NK, Dragsted N, Lassen AB, Laursen M, Bass AS, Valentin J, Markgraf C, Authier S, Baird TJ, Bhatt S, Traebert M, Leishman DJ, Jones D, Curtis MJ. Is there a role for the no observed adverse effect level in safety pharmacology? Journal of Pharmacological and Toxicological Methods 2020;105:106917. [DOI: 10.1016/j.vascn.2020.106917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lynch JJ 3rd, Van Vleet TR, Mittelstadt SW, Blomme EAG. Potential functional and pathological side effects related to off-target pharmacological activity. J Pharmacol Toxicol Methods 2017;87:108-26. [PMID: 28216264 DOI: 10.1016/j.vascn.2017.02.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
15 Xing G, Lu J, Hu M, Wang S, Zhao L, Zheng W, Schofield J, Oldman K, Adkins D, Yu H, Platz S, Ren J, Skinner M. Effects of group housing on ECG assessment in conscious cynomolgus monkeys. J Pharmacol Toxicol Methods 2015;73:72-9. [PMID: 25901446 DOI: 10.1016/j.vascn.2015.04.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Klein SK, Redfern WS. Cardiovascular safety risk assessment for new candidate drugs from functional and pathological data: Conference report. J Pharmacol Toxicol Methods 2015;76:1-6. [PMID: 26126834 DOI: 10.1016/j.vascn.2015.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Tse K, Sillito R, Keerie A, Collier R, Grant C, Karp NA, Vickers C, Chapman K, Armstrong JD, Redfern WS. Pharmacological validation of individual animal locomotion, temperature and behavioural analysis in group-housed rats using a novel automated home cage analysis system: A comparison with the modified Irwin test. J Pharmacol Toxicol Methods 2018;94:1-13. [PMID: 29614333 DOI: 10.1016/j.vascn.2018.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Authier S, Arezzo J, Delatte MS, Kallman MJ, Markgraf C, Paquette D, Pugsley MK, Ratcliffe S, Redfern WS, Stevens J, Valentin JP, Vargas HM, Curtis MJ. Safety pharmacology investigations on the nervous system: An industry survey. J Pharmacol Toxicol Methods 2016;81:37-46. [PMID: 27263834 DOI: 10.1016/j.vascn.2016.06.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
19 Barker-haliski M, Friedman D, White H, French J. How Clinical Development Can, and Should, Inform Translational Science. Neuron 2014;84:582-93. [DOI: 10.1016/j.neuron.2014.10.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
20 Authier S, Vargas HM, Curtis MJ, Holbrook M, Pugsley MK. Safety pharmacology investigations in toxicology studies: An industry survey. Journal of Pharmacological and Toxicological Methods 2013;68:44-51. [DOI: 10.1016/j.vascn.2013.05.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
21 Goineau S, Lemaire M, Froget G. Overview of safety pharmacology. Curr Protoc Pharmacol 2013;63:Unit 10.1.. [PMID: 24510755 DOI: 10.1002/0471141755.ph1001s63] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
22 Benjamin A, Gallacher DJ, Greiter-Wilke A, Guillon JM, Kasai C, Ledieu D, Levesque P, Prelle K, Ratcliffe S, Sannajust F, Valentin JP. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies. J Pharmacol Toxicol Methods 2015;75:101-10. [PMID: 25637943 DOI: 10.1016/j.vascn.2015.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
23 Fares R, Flénet T, Vial J, Ravaz M, Roger V, Bory C, Baudet S. Non invasive jacketed telemetry in socially-housed rats for a combined assessment of respiratory system, electrocardiogram and activity using the DECRO system. J Pharmacol Toxicol Methods 2022;:107195. [PMID: 35779850 DOI: 10.1016/j.vascn.2022.107195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Andersen NK, Meyer O, Bradley A, Dragsted N, Lassen AB, Sjögren I, Larsen JM, Harvey W, Bator R, Milne A. Evaluation of the PhysioTel™ Digital M11 cardiovascular telemetry implant in socially housed cynomolgus monkeys up to 16 weeks after surgery. Journal of Pharmacological and Toxicological Methods 2017;87:82-92. [DOI: 10.1016/j.vascn.2017.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]